Newer Nephrotoxic Agents

  • Carlos A. Vaamonde


There are numerous substances capable of affecting the kidneys and producing renal dysfunction or disease. Nephrotoxicity has been associated with acute or chronic poisoning, which may be accidental or suicidal in origin (HgCl2, ethylene glycol, CCl4), while in other cases results from exposure to industrial or environmental hazards (lead, mercury, CCl4, cadmium, hydrocarbons). Although these forms of nephrotoxicity are important to physicians, the most prevalent cause of nephrotoxicity now-a-days is drug induced (Table 1).


Interstitial Nephritis Renal Tubular Acidosis Nephrogenic Diabetes Insipidus Acute Interstitial Nephritis Nephrotoxic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Reidenberg, M.M.: Renal Function and Drug Action. Saunders, Philadelphia, 1971.Google Scholar
  2. 2.
    Anderson, R.J., Gambertoglio, J.G. and Schrier, R.W.: Clinical use of drugs in renal failure. Thomas, Springfield, 1976.Google Scholar
  3. 3.
    Bennett, W.M., Porter, G.A., Bagby, S.P. and McDonald, W.J.: Drugs and Renal Disease. Churchill Livingstone, New York, 1978.Google Scholar
  4. 4.
    Bennett, W.M., Singer, I., Golper, T., Feig, P., and Coggins, C.J.: Guideline for Drug Therapy in Renal Failure. Ann. Intern. Med. 86: 754, 1977.PubMedGoogle Scholar
  5. 5.
    Rubin, A.L., Stenzel, K.H. and Reidenberg, M.M.: Symposium on drug action and metabolism in renal failure. Am. J. Med. 62: 459–562, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Cafruny, E.J.: Renal tubular handling of drugs. Am. J. Med. 62: 490, 1977.PubMedCrossRefGoogle Scholar
  7. 7.
    Reidenberg, M.M.: The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am. J. Med. 62: 466, 1977.PubMedCrossRefGoogle Scholar
  8. 8.
    Falco, F.G., Smith, H.M. and Arcieri, G.M.: Nephrotoxicity of aminoglycoside and gentamicin. J. Infect. Dis. 119: 406, 1969.PubMedCrossRefGoogle Scholar
  9. 9.
    Fiilastre, J-P. (ed.): Nephrotoxicity. Interaction of drugs with membranes systems Mitochondria-lysosomes. Masson Publishing USA, Inc., New York, 1978.Google Scholar
  10. 10.
    Hewitt, W.L.: Gentamicin: toxicity in perspective. Postgrad. Med. J. 50: (Suppl. 7) 55, 1974.PubMedGoogle Scholar
  11. 11.
    Appel, G.B. and Neu, H.C.: Gentamicin in 1978. Ann. Intern. Med. 89: 528, 1978.PubMedGoogle Scholar
  12. 12.
    Cronin, R.E.: Aminoglycoside nephrotoxicity: pathogenesis and prevention. Clin. Nephrol. 11: 251, 1979.PubMedGoogle Scholar
  13. 13.
    Gilbert, D.N., Bennett, W.M., Houghton, D.C. and Porter, G.: Comparative nephrotoxicity of gentamicin and tobramycin. Clin. Res. 25: 376A, 1977.Google Scholar
  14. 14.
    Dikman, S., Bosch, J., Chung, J. and Kahn, T.: Gentamicin and netilmicin nephrotoxicity. Antimicrob. Agents Chemother. 10: 827, 1976.Google Scholar
  15. 15.
    Ormsby, A., Plamp, C., Bennett, W., Gilbert, D., Houghton, D. and Porter, G.: Comparison of the nephrotoxic potential of gentamicin (G), tobramycin (T) and netilmicin (N) in the rat. Clin. Res. 26: 141A, 1978.Google Scholar
  16. 16.
    Luft, F.C., Bloch, R., Sloan, R.S., Yum, M.N., Costello, R. and Maxwell, D.R.: Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J. Inf. Dis. 138: 541, 1978.CrossRefGoogle Scholar
  17. 17.
    Robbins, G. and Tetterborn, D.: Toxicity of sisomicin in animals. Infection 4 (Suppl.): 349, 1976.CrossRefGoogle Scholar
  18. 18.
    Zakauddin, S. and Adelman, R.: Urinary enzyme activity in neonates receiving gentamicin therapy. Clin. Res. 26: 142A, 1978.Google Scholar
  19. 19.
    Cowan, R.H., Jukkola, A.F. and Arant, B.S., Jr.: Pathophysiological evidence of gentamicin (G) nephrotoxicity in the neonatal puppy. Kidney Int. 14: 628, 1978.Google Scholar
  20. 19a.
    Karniski, L., Chonko, A., Stewart, R., Cuppage, F. and Hodges, G.: The effects of gentamicin (G) on renal function in the sexually mature vs. sexually immature rabbits. Kidney Int. 14: 726, 1978.Google Scholar
  21. 20.
    Plummer, D.T. and Ngaha, E.O.: Urinary enzymes as an index of kidney damage by toxic compounds In Nephrotoxicity. Fillastre, J-P., Masson Publishing USA, p. 175–191, 1978.Google Scholar
  22. 21.
    Cronin, R.E.: Aminoglycoside induced glycosuria in the dog. Clin. Res. 26: 461A, 1978.Google Scholar
  23. 22.
    Holmes, A.M., Hesling, C.M. and Wilson, T.M.: Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis. Q.J. Med. 39: 299, 1970.PubMedGoogle Scholar
  24. 23.
    Patel, R. and Savage, A.: Symptomatic hypomagnesemia associated with gentamicin therapy. Nephron 23: 50, 1979.PubMedCrossRefGoogle Scholar
  25. 24.
    Teixeira, R.B., Alpert, H.C., Kelley, J and Vaamonde, C.A.: Protection from gentamicin-induced acute renal failure in the rat (unpublished observations).Google Scholar
  26. 25.
    Lane, A.Z., Wright, G.E. and Blair, D.C.: Ototoxicity and nephrotoxicity of amikacin. Am. J. Med. 62: 911, 1977.PubMedCrossRefGoogle Scholar
  27. 26.
    Bennett, W.M., Hartnett, M.N., Gilbert, D., Houghton, D. and Porter, G.A.: Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc. Soc. Exp. Biol. Med. 151: 736, 1976.PubMedGoogle Scholar
  28. 27.
    Barr, G.A., Mazze, R.I., Cousins, M.J. and Kosek, J.C.: An animal model for combined methoxyflurane and gentamicin nephrotoxicity. Br. J. Anaesth. 45: 306, 1973.PubMedCrossRefGoogle Scholar
  29. 28.
    Adelman, R.D., Conzelman, G., Spangler, W. and Ishiyaki, G.: Furosemide potentiated gentamicin nephrotoxicity: early detection by monitoring of urinary enzymes. Kidney Int. 12: 538, 1977.Google Scholar
  30. 29.
    Cabanillas, F., Burgos, R.C., Rodriguez, R.C. and Baldizon, C: Nephrotoxicity of combined cephalothin-gentamicin regimen. Arch. Intern. Med. 135: 850, 1975.PubMedCrossRefGoogle Scholar
  31. 30.
    Plager, J.E.: Association of renal injury with combined ce-phalothin gentamicin therapy among patients severely ill with malignant disease. Cancer 37: 1937, 1976.PubMedCrossRefGoogle Scholar
  32. 31.
    Yuer, L., Becq-Giraudon, B., Pourrat, O. et Sudre, Y.: La néphrotoxicite de l’association méthicilline-gentamycine. Sem. Hôp. Paris 52: 1903, 1976.Google Scholar
  33. 32.
    Dellinger, P., Murphy, T., Barza, M., Pinn, V. and Weinstein, L.: Effect of cephalothin on renal cortical concentrations of gentamicin in rats. Antimicrob. Agents Chemother. 9: 587, 1976.PubMedGoogle Scholar
  34. 33.
    Whelton, A.: Intrarenal antibiotic distribution in health and disease. Kidney Int. 6: 131, 1974.PubMedCrossRefGoogle Scholar
  35. 34.
    Luft, F.C., Patel, V., Yum, M., Patel, B. and Kleit, S.: Experimental aminoglycoside nephrotoxicity. J. Lab. Clin. Med. 86: 213, 1975.PubMedGoogle Scholar
  36. 35.
    Kosek, J.C., Mazze, R.I. and Cousins, M.J.: Nephrotoxicity of gentamicin. Lab. Invest. 30: 48, 1974.PubMedGoogle Scholar
  37. 36.
    Baylis, C., Rennke, H.R. and Brenner, B.M.: Mechanisms of the defect in glomerular ultrafiltration associated with gentamicin administration. Kidney Int. 12: 344, 1977.PubMedCrossRefGoogle Scholar
  38. 37.
    Baylis, C.: Mechanisms involved in gentamicin-induced acute renal failure. Kidney Int. 15: 445, 1979.CrossRefGoogle Scholar
  39. 38.
    Mattson, K., Riska, H., Forsström, J. and Kock, B.: Acute renal failure following rifampin administration. Scand. J. Resp. Dis. 55: 291, 1974.Google Scholar
  40. 39.
    Campese, V.M., Marzullo, F., Schema, F.P. and Coratelli, P.: Acute renal failure during intermittent rifampin therapy. Nephron 10: 256, 1973.PubMedCrossRefGoogle Scholar
  41. 40.
    Kleinknecht, D., Homberg, J.D. and Decroix, G.: Acute renal failure after rifampin. Lancet 1: 1238, 1972.PubMedCrossRefGoogle Scholar
  42. 41.
    Gabow, P.A., Lacher, J.W. and Neff, T.A.: Tubulointerstitial glomerular nephritis associated with rifampin. Report of a case. JAMA 235: 2517, 1976.PubMedCrossRefGoogle Scholar
  43. 42.
    Hardaker, W.T., Jr., Stone, R.A. and McCoy, R.: Platinum nephrotoxicity. Cancer 34: 1030, 1974.PubMedCrossRefGoogle Scholar
  44. 43.
    Gonzalez-Vitale, J.C., Hayes, D.M., Cvitkovic, E. and Sternberg, S.S.: The renal pathology in clinical trials of Cis-platinum (II) diamminedichloride. Cancer 39: 1362, 1977.CrossRefGoogle Scholar
  45. 44.
    Gonzalez-Vitale, J.C., Hayes, D.M., Cvitkovic, E. and Sternberg, S.S.: Acute renal failure after Cis-Dichlorodiammineplatinum (II) and gentamicin-cephalothin therapies. Cancer Treat. Rep. 62: 693, 1978.PubMedGoogle Scholar
  46. 45.
    Dentino, M., Luft, F.C., Yum, M.N., Williams, S.D. and Einhorn, L.H.: Long term effect of Cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer 41: 1274, 1978.PubMedCrossRefGoogle Scholar
  47. 46.
    Levi, J., Jacobs, C., McTigue, M. and Weiner, M.W.: Mechanism of Cis-diamminedichloroplatinum (Cis-Pt) nephrotoxicity. Clin. Res. 27: 422A, 1979.Google Scholar
  48. 47.
    Schilsky, R.L. and Anderson, T.: Hypomagnesemia and renal magnesium wasting in patients receiving Cisplatin. Ann. Intern. Med. 90: 929, 1979.PubMedGoogle Scholar
  49. 48.
    Nitschke, R., Starling, K.A., Vats, T. and Bryan, H.: Cis-diamminedichloroplatinum (NSC-119875) in childhood malignancies: a Southwest Oncology Group Study. Med. Pediatr. Oncol. 4: 127, 1978.PubMedCrossRefGoogle Scholar
  50. 49.
    Schacht, U.C. and Baldwin, D.S.: Chronic interstitial nephritis and renal failure due to nitrosourea (NU) therapy. Kidney Int. 14: 661, 1978.Google Scholar
  51. 50.
    Harmon, W.E., Cohen, H.J., Schneeberger, E.E. and Grupe, W.E.: Chronic renal failure in children treated with methyl CCNU. N. Eng. J. Med. 300: 1200, 1979.CrossRefGoogle Scholar
  52. 51.
    Shafi, T., Chou, S., Porush, J. and Shapiro, W.B.: Infusion intravenous pyelography and renal function effects in patients with chronic renal insufficiency. Arch. Intern. Med. 138: 1218, 1978.PubMedCrossRefGoogle Scholar
  53. 52.
    Swartz, R.D., Rubin, J.E., Leeming, B.W. and Silva, P.: Renal failure following major angiography. Am. J. Med. 65: 31, 1978.PubMedCrossRefGoogle Scholar
  54. 53.
    Van Zee, B.E., Hoy, W.E., Talley, T.E. and Jaenike, J.R.: Renal injury associated with intravenous pyelography in non-diabetic and diabetic patients. Ann. Intern. Med. 89: 51, 1978.Google Scholar
  55. 54.
    Heneghan, M.: Contrast-induced acute renal failure. Editorial Am. J. Roentgenol. 131: 1113, 1978.Google Scholar
  56. 55.
    Byrd, L. and Sherman, R.L.: Radiocontrast-induced acute renal failure: A clinical and pathophysiological review. Medicine 58: 270, 1979.PubMedCrossRefGoogle Scholar
  57. 56.
    Canales, C.O., Smith, G.H., Robinson, J.C., Remmers, A.R. and Sarles, H.E.: Acute renal failure after the administration of iopanoic acid as a cholecystographic agent. N. Engl. J. Med. 281: 89, 1969.PubMedCrossRefGoogle Scholar
  58. 57.
    Berezin, A.F.: Acute renal failure, diabetes mellitus, and scanning. Ann. Intern. Med. 86: 829, 1977.PubMedGoogle Scholar
  59. 58.
    Hanaway, J. and Black, J.: Renal failure following contrast injection for computerized tomography. JAMA 238: 2056, 1977.PubMedCrossRefGoogle Scholar
  60. 59.
    Takazahura, E., Sawabu, N., Handa, A., Takada, A., Shinoda, A. and Takeuchi, J.: Intrarenal vascular changes with age and disease. Kidney Int. 2: 224, 1972.CrossRefGoogle Scholar
  61. 60.
    Hollenberg, N.K., Adams, D.F., Solomon, H.S., Rashid, A., Abrams, H.L. and Merrill, J.P.: Senescence and the renal vasculature in normal man, Circ. Res. 34: 309, 1974.PubMedGoogle Scholar
  62. 61.
    Ansari, Z. and Baldwin, D.S.: Acute renal failure due to radiocontrast agents. Nephron 17: 28, 1976.PubMedCrossRefGoogle Scholar
  63. 62.
    Harkonen, S. and Kjellstrand, K.M.: Exacerbation of diabetic renal failure following intravenous pyelography. Am. J. Med. 63: 939, 1977.PubMedCrossRefGoogle Scholar
  64. 63.
    Dudzinski, P.J., Petrone, A.F., Peroff, M. and Callaghan, E.E.: Acute renal failure following high-dose excretory urography in dehydrated patients. J. Urol. 106: 619, 1971.PubMedGoogle Scholar
  65. 64.
    Kamdar, A., Weidmann, P., Makoff, D.L. and Massry, S.G.: Acute renal failure following intravenous use of radiographic contrast dyes in patients with diabetes mellitus. Diabetes 26: 643, 1977.PubMedCrossRefGoogle Scholar
  66. 65.
    Veseley, D.L. and Mintz, D.H.: Acute renal failure in insulin-dependent diabetics. Episodes secondary to intravenous pyelography. Arch. Intern. Med. 138: 1858, 1978.CrossRefGoogle Scholar
  67. 66.
    Pillay, V.K., Robbins, P.C., Schwartz, F.D. and Kark, R.M.: Acute renal failure following intravenous urography in patients with long-standing diabetes mellitus and azotemia. Radiology 95: 633, 1970.PubMedGoogle Scholar
  68. 67.
    Barshay, M.E., Kay, J.H., Goldman, R. and Coburn, V.W.: Acute renal failure in diabetic patients after infusion pyelography. Clin. Nephrol. 1: 35, 1973.PubMedGoogle Scholar
  69. 68.
    Diaz-Buxo, J.A., Wagoner, R.D., Hattery, R.R. and Palumbo, P.J.: Acute renal failure after excretory urography. Ann. Intern. Med. 83: 155, 1975.PubMedGoogle Scholar
  70. 69.
    DeFronzo, R.A., Humphrey, R.L., Wright, J.R. and Cooke, C.R.: Acute renal failure in multiple myeloma. Medicine 54: 209, 1975.PubMedCrossRefGoogle Scholar
  71. 70.
    Norby, L.H. and DiBona, G.F.: The renal vascular effects of meglumide diatrizoate. J. Pharmacol. Exper. Ther. 193: 932, 1975.Google Scholar
  72. 71.
    Lasser, E.C.: Contrast-material red blood cell reactions. Editorial. Invest. Radiol. 8: 189, 1973.CrossRefGoogle Scholar
  73. 72.
    Talner, L.B., Rushman, H.N. and Goel, M.N.: The effect of renal artery injection of contrast material on urinary enzyme excretion. Invest. Radiol. 7: 311, 1972.PubMedCrossRefGoogle Scholar
  74. 73.
    Ziegler, T.W., Ladens, J.H., Fanestil, D.D. and Talner, L.B.: Inhibition of active sodium transport by radiographic contrast media. Kidney Int. 7: 68, 1975.PubMedCrossRefGoogle Scholar
  75. 74.
    Postelthwaite, A.E. and Kelley, W.N.: Uricosuric effect of radiocontrast agents. Ann. Intern. Med. 74: 845, 1971.Google Scholar
  76. 75.
    Gelman, M.L., Rowe, J.W., Coggins, C.H. and Athanasoulis, C.: Effects of an angiographic contrast agent on renal function. Cardiovasc. Med. 4: 313, 1979.Google Scholar
  77. 76.
    Anto, H.R., Chou, S-Y., Porush, J.G. and Shapiro, W.B.: Man-nitol prevention of acute renal failure (ARF) associated with infusion intravenous pyelography (IIVP). Clin. Res. 27: 407A, 1979.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • Carlos A. Vaamonde
    • 1
  1. 1.Dept. Med., Div. Nephrol. Veterans Admn. Med. Ctr.Univ. Miami Sch. Med.MiamiUSA

Personalised recommendations